|
Volumn 24, Issue 4, 2006, Pages 368-
|
Transgenic milk prospects turn sour
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
N GLYCOLOYLNEURAMINIC ACID;
OLIGOSACCHARIDE;
RECOMBINANT ANTITHROMBIN ALPHA;
RECOMBINANT ANTITHROMBIN III;
RECOMBINANT PROTEIN;
UNCLASSIFIED DRUG;
ANTITHROMBIN DEFICIENCY;
CHICKEN;
CLINICAL TRIAL;
COW;
DEEP VEIN THROMBOSIS;
DRUG HALF LIFE;
EDITORIAL;
HUMAN;
IMMUNOGENICITY;
MAMMARY GLAND;
MILK;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN GLYCOSYLATION;
RABBIT;
SHEEP;
TRANSGENIC ANIMAL;
TRANSGENICS;
UNITED STATES;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
EUROPE;
EUROPEAN UNION;
HUMANS;
MILK;
MILK PROTEINS;
RECOMBINANT PROTEINS;
ANIMALIA;
ORYCTOLAGUS CUNICULUS;
OVIS ARIES;
|
EID: 33645732492
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0406-368b Document Type: Editorial |
Times cited : (2)
|
References (0)
|